CTAG2 and urinary bladder carcinoma: NY-ESO-1 and LAGE-1 are antigens expressed by testicular germ cells and a limited number of tumors; however, previous results indicate that almost 50% of high grade urothelial carcinomas express one or both of these antigens, and thus, a vaccine for either may prove beneficial in bladder cancer [62].